HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Optimal Management of Asymptomatic Carotid Stenosis in 2021: The Jury is Still Out. An International, Multispecialty, Expert Review and Position Statement.

AbstractOBJECTIVES:
The recommendations of international guidelines for the management of asymptomatic carotid stenosis (ACS) often vary considerably and extend from a conservative approach with risk factor modification and best medical treatment (BMT) alone, to a more aggressive approach with a carotid intervention plus BMT. The aim of the current multispecialty position statement is to reconcile the conflicting views on the topic.
MATERIALS AND METHODS:
A literature review was performed with a focus on data from recent studies.
RESULTS:
Several clinical and imaging high-risk features have been identified that are associated with an increased long-term ipsilateral ischemic stroke risk in patients with ACS. Such high-risk clinical/imaging features include intraplaque hemorrhage, impaired cerebrovascular reserve, carotid plaque echolucency/ulceration/ neovascularization, a lipid-rich necrotic core, a thin or ruptured fibrous cap, silent brain infarction, a contralateral transient ischemic attack/stroke episode, male patients < 75 years and microembolic signals on transcranial Doppler. There is growing evidence that 80-99% ACS indicate a higher stroke risk than 50-79% stenoses.
CONCLUSIONS:
Although aggressive risk factor control and BMT should be implemented in all ACS patients, several high-risk features that may increase the risk of a future cerebrovascular event are now documented. Consequently, some guidelines recommend a prophylactic carotid intervention in high-risk patients to prevent future cerebrovascular events. Until the results of the much-anticipated randomized controlled trials emerge, the jury is still out regarding the optimal management of ACS patients.
AuthorsKosmas I Paraskevas, Dimitri P Mikhailidis, Pier Luigi Antignani, Hediyeh Baradaran, Reinoud P H Bokkers, Richard P Cambria, Alan Dardik, Alun H Davies, Hans-Henning Eckstein, Gianluca Faggioli, Jose Fernandes E Fernandes, Gustav Fraedrich, George Geroulakos, Peter Gloviczki, Jonathan Golledge, Ajay Gupta, Mateja K Jezovnik, Stavros K Kakkos, Niki Katsiki, Michael Knoflach, M Eline Kooi, Gaetano Lanza, Christos D Liapis, Ian M Loftus, Armando Mansilha, Antoine Millon, Andrew N Nicolaides, Rodolfo Pini, Pavel Poredos, Jean-Baptiste Ricco, Thomas S Riles, Peter Arthur Ringleb, Tatjana Rundek, Luca Saba, Felix Schlachetzki, Mauro Silvestrini, Francesco Spinelli, Francesco Stilo, Sherif Sultan, Jasjit S Suri, Clark J Zeebregts, Seemant Chaturvedi
JournalJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (J Stroke Cerebrovasc Dis) Vol. 31 Issue 1 Pg. 106182 (Jan 2022) ISSN: 1532-8511 [Electronic] United States
PMID34735900 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2021 Elsevier Inc. All rights reserved.
Topics
  • Carotid Stenosis (therapy)
  • Humans
  • Practice Guidelines as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: